tiprankstipranks
Tetra Bio-Pharma Inc (TSE:TBP)
TSX:TBP
Canadian Market
Holding TSE:TBP?
Track your performance easily

Tetra Bio-Pharma (TBP) Income Statement

81 Followers

Tetra Bio-Pharma Income Statement

Last quarter (Q3 2022), Tetra Bio-Pharma's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Tetra Bio-Pharma's net income was C$-3.49M. See Tetra Bio-Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Nov 21Nov 20Nov 19Nov 18Nov 17
Total Revenue
---C$ 0.00C$ 0.00C$ 0.00
Cost of Revenue
----C$ 67.59KC$ 0.00
Gross Profit
----C$ 44.73KC$ 0.00
Operating Expense
C$ 12.96MC$ 24.30MC$ 20.46MC$ 12.95MC$ 11.58MC$ 6.23M
Operating Income
C$ -12.96MC$ -24.30MC$ -20.46MC$ -12.95MC$ -11.58MC$ -6.23M
Net Non Operating Interest Income Expense
C$ -2.21MC$ 1.79MC$ -98.01KC$ 89.77KC$ 113.96KC$ 487.00
Other Income Expense
C$ -22.83MC$ -26.09MC$ 268.47KC$ -224.97KC$ 3.62MC$ -465.36K
Pretax Income
C$ -39.02MC$ -52.18MC$ -20.95MC$ -13.08MC$ -7.84MC$ -6.70M
Tax Provision
-----C$ 0.00
Earnings From Equity Interest Net Of Tax
C$ -76.37KC$ -651.19KC$ -268.47K---
Net Income Common Stockholders
C$ -39.02MC$ -52.18MC$ -15.63MC$ -15.28MC$ -7.57MC$ -6.23M
Basic EPS
C$ -0.06C$ -0.12C$ 0.10C$ -0.08C$ -0.05C$ -0.06
Diluted EPS
C$ -0.06C$ -0.12C$ 0.10C$ -0.08C$ -0.05C$ -0.06
Basic Average Shares
C$ 1.65BC$ 445.70MC$ 258.15MC$ 188.24MC$ 145.69MC$ 107.80M
Diluted Average Shares
C$ 1.65BC$ 445.70MC$ 258.15MC$ 188.24MC$ 145.69MC$ 107.80M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 0.00C$ 18.00K
Total Expenses
C$ 6.48MC$ -24.30MC$ -20.46MC$ 12.95MC$ 11.58MC$ 6.23M
Interest Expense
C$ 139.70K-----
Net Income From Continuing And Discontinued Operation
C$ -39.02MC$ -52.18MC$ -15.63MC$ -15.28MC$ -7.57MC$ -6.23M
Normalized Income
C$ -11.41MC$ -14.37MC$ -15.00MC$ -12.86MC$ -11.18MC$ -5.76M
EBIT
C$ -37.36MC$ -50.28MC$ -20.95MC$ -12.95MC$ -11.58MC$ -6.23M
EBITDA
C$ -37.26MC$ -50.17MC$ -20.92MC$ -12.92MC$ -11.58MC$ -6.22M
Currency in CAD

Tetra Bio-Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis